Ovarian Mixed Cell Adenocarcinoma Clinical Trials in Rochester, Minnesota

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial